Mark Adams

Venture Partner, Two Bear Capital

Mark Adams was the chief operating officer of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Prior to joining Adaptive, Mark served as managing director of healthcare advanced analytics at SVB Leerink, a health and life sciences-focused investment bank, since April 2018. Mark has also served as chief information officer at Celmatix, a women’s health precision medicine company, from September 2016 to April 2018, and at Good Start Genetics, a molecular diagnostics company. Mark holds a bachelor’s from Oberlin College and a PhD from Baylor College of Medicine.